SCHEMBL8704875

SCHEMBL8704875

COc1ccccc1CCCCc1ccccc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.69
TAAR1 Q96RJ0 1/20 0.56
ALOX5 P09917 1/20 0.56
PTGS2 P35354 1/20 0.56
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
TP53 P04637 1/20 0.55
TSHR P16473 1/20 0.55
SIGMAR1 Q99720 1/20 0.50
AOC3 Q16853 1/20 0.50
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
NPC1 O15118 1/20 0.49
PKM P14618 1/20 0.49
RAB9A P51151 1/20 0.49
MAPT P10636 1/20 0.49
CA12 O43570 1/20 0.49
CA5A P35218 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8704419 0.92 MPO (0.68) MPOTAAR1CA1CA2TP53
Guaiacol SCHEMBL28149340 0.84 CA1 (0.60) MPOTAAR1ALOX5PTGS2CA1
SCHEMBL7831226 0.84 TAAR1 (0.69) MPOTAAR1CA1CA2SIGMAR1
SCHEMBL7650103 0.83 TAAR1 (0.58) MPOTAAR1ALOX5PTGS2SIGMAR1
SCHEMBL31277350 0.83 TAAR1 (0.58) MPOTAAR1ALOX5PTGS2SIGMAR1
SCHEMBL3800530 0.82 TAAR1 (0.65) MPOTAAR1CA2TSHRCA12
SCHEMBL80578 0.81 TAAR1 (0.60) MPOTAAR1ALOX5PTGS2SIGMAR1
SCHEMBL30118916 0.81 TAAR1 (0.60) MPOTAAR1ALOX5PTGS2SIGMAR1
SCHEMBL10987745 0.81 HSPA5 (0.64) MPOTAAR1CA1CA2TP53
SCHEMBL581720 0.81 ALOX5 (0.69) MPOTAAR1ALOX5PTGS2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
CN-1102640-A Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory and psychiatric disorders SANKYO CO (JP) 1995-05-17 CN disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed